|
Volumn 25, Issue 9, 1999, Pages 470-479
|
Assessing "best evidence": issues in grading the quality of studies for systematic reviews.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
EPIDEMIOLOGY;
EVIDENCE BASED MEDICINE;
GOVERNMENT;
HUMAN;
META ANALYSIS;
METHODOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCIBILITY;
REVIEW;
SENSITIVITY AND SPECIFICITY;
STANDARD;
STATISTICAL ANALYSIS;
UNITED STATES;
BIAS (EPIDEMIOLOGY);
DATA INTERPRETATION, STATISTICAL;
EVIDENCE-BASED MEDICINE;
HUMANS;
META-ANALYSIS;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
SENSITIVITY AND SPECIFICITY;
UNITED STATES;
UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;
|
EID: 0033194558
PISSN: 10703241
EISSN: None
Source Type: Journal
DOI: 10.1016/S1070-3241(16)30461-8 Document Type: Article |
Times cited : (118)
|
References (36)
|